As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more flexible, data-driven approaches that integrate prior knowledge, reduce sample ...

Jessica Ritsick, Yifan Wang, Ph.D. Our FDA: Drug & Device Team analyzes the Food and Drug Administration’s new guidance on Bayesian approaches to innovative drug trials, providing greater clarity on ...

In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.

Marty Makary was appointed commissioner of the Food and Drug Administration (FDA) in 2025. The prominent surgeon, medical researcher, bestselling author, and critic of the medical ...

This is a preview. Log in through your library . Series B (Statistical Methodology) of the Journal of the Royal Statistical Society started out simply as the Supplement to the Journal of the Royal ...